← Back to Patent Explorer
US4228099A Expired / Lapsed US ⏱️ 0.0 years remaining

Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

Assignee: Johns Hopkins University
•
Filing: 1978-03-17
•
Granted: 1980-10-14
•
Expires: 1998-03-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel compounds are prepared by reacting ornithine or arginine with alpha keto analogs of branched chain essential amino acids, namely valine, leucine and isoleucine. The compounds are useful either individually or as a mixture in the treatment of hepatic disorders which are characterized by hyperammonemia and portal systemic encephalopathy. Use of these compounds in treatment of renal failure also appears promising.

Inventors

  • 👤 Mackenzie Walser

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 14:01
CPC Classifications
C; C07; C07C; C07C59/00; C07C59/185; A; A61; A61P; A61P1/00; A61P1/16; A61P13/00; A61P13/02; A61P15/00

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 39 words
Compounds of the formula: AK.xH.sub.2 O wherein A is selected from the group consisting of arginine and ornithine, K is an alpha keto analog of a branched chain essential amino acid, and x varies from zero to about one.
Claim 2
Dependent Claim 39 words
Compounds of the formula: AK.xH.sub.2 O wherein A is selected from the group consisting of arginine and ornithine, K is an alpha keto analog of a branched chain essential amino acid, and x varies from zero to about one.
Claim 3
Dependent Claim 13 words
Compounds according to claim 1 wherein A is ornithine and x is zero.
Claim 4
Dependent Claim 2 words
Arginine α-ketoisocaproate.
Claim 5
Dependent Claim 2 words
Arginine α-ketoisocaproate.
Claim 6
Dependent Claim 2 words
Arginine α-ketoisovalerate.
Claim 7
Dependent Claim 2 words
Arginine α-ketoisovalerate.
Claim 8
Dependent Claim 2 words
Arginine α-keto-β-methylvalerate.
Claim 9
Dependent Claim 2 words
Arginine α-keto-β-methylvalerate.
Claim 10
Dependent Claim 2 words
Ornithine α-ketoisocaproate.
Claim 11
Dependent Claim 2 words
Ornithine α-ketoisocaproate.
Claim 12
Dependent Claim 2 words
Ornithine α-ketoisovalerate.
Claim 13
Dependent Claim 2 words
Ornithine α-ketoisovalerate.
Claim 14
Dependent Claim 2 words
Ornithine α-keto-β-methylvalerate.
Claim 15
Dependent Claim 2 words
Ornithine α-keto-β-methylvalerate.

References Cited (Backward Citations)

CA814483A Cited
GB1034358A Cited
FR1432756A Cited
US3441650A Cited
FR2226993B1 Cited
US4100293A Cited
US3950529A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-10-14 1984-04-14 1984-10-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-10-14 1988-04-14 1988-10-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-10-14 1992-04-14 1992-10-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag